Fem-dophilus contains two patented and clinically proven probiotic strains, Lactobacillus GR-1 and Lactobacillus RC-14 discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. More than 30 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal and urinary tracts. Fem-dophilus also supports immune system health.
Supplement Facts
Serving Size 1 Capsule
Servings Per Container 30
| Amount Per Serving | % Daily Value |
|---|---|
| Proprietary Probiotic Blend 134 mg (5 Billion CFU §) | † |
| Lacticaseibacillus rhamnosus, GR-1® | * |
| Limosilactobacillus reuteri, RC-14® | * |
§ Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
†† Daily Value not established.
Other Ingredients: Maltodextrin, capsule (hydroxypropylmethylcellulose, titanium dioxide [color]), microcrystalline cellulose and magnesium stearate (vegetable source)
Suggested Use: Adults take 1 capsule once a day. May be taken with or without food. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Warning: Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication or have a medical condition; if adverse reactions occur, discontinue use.
Storage Instructions: Do not use if safety seal is damaged or missing. Keep out of the reach of children. Keep Refrigerated.
Country of Origin: Made in Denmark by Chr. Hansen A/S
Trademark Information: RC-14® and GR-1® are Trademarks of Chr. Hansen A/S.
Other Information: No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame., Manufactured in a facility that produces dairy containing products, 2 Effective Strains
